Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedFeb 28, 2018Tretinoin USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0530-2018Class IITerminatedFeb 28, 2018Tramadol HCl USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0529-2018Class IITerminatedFeb 28, 2018Testosterone USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0528-2018Class IITerminatedFeb 28, 2018Testosterone Enanthate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0527-2018Class IITerminatedFeb 28, 2018Testosterone Cypionate USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0526-2018Class IITerminatedFeb 28, 2018TestosteroneCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0525-2018Class IITerminatedFeb 28, 2018Tadalafil USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0524-2018Class IITerminatedFeb 28, 2018Tacrolimus USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0523-2018Class IITerminatedFeb 28, 2018Sumatriptan USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0522-2018Class IITerminatedFeb 28, 2018Sumatriptan Succinate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0521-2018Class IITerminatedFeb 28, 2018Stanozolol USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0520-2018Class IITerminatedFeb 28, 2018Sildenafil Citrate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0519-2018Class IITerminatedFeb 28, 2018Progesterone USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0518-2018Class IITerminatedFeb 28, 2018Prilocaine HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0517-2018Class IITerminatedFeb 28, 2018Phentolamine Mesylate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0516-2018Class IITerminatedFeb 28, 2018Pentoxifylline USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0515-2018Class IITerminatedFeb 28, 2018Oxandrolone USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0514-2018Class IITerminatedFeb 28, 2018Nifedipine USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0513-2018Class IITerminatedFeb 28, 2018Nandrolone Decanoate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0512-2018Class IITerminatedFeb 28, 2018Naltrexone HCl USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0511-2018Class IITerminatedFeb 28, 2018Medroxyprogesterone Acetate USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0510-2018Class IITerminatedFeb 28, 2018Liothyronine Sodium USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0509-2018Class IITerminatedFeb 28, 2018Lincomycin HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0508-2018Class IITerminatedFeb 28, 2018Lidocaine USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0507-2018Class IITerminatedFeb 28, 2018Lidocaine HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0506-2018Class IITerminatedFeb 28, 2018Levothyroxine Sodium USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0505-2018Class IITerminatedFeb 28, 2018Levofloxacin Hemihydrate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0504-2018Class IITerminatedFeb 28, 2018Levocetirizine Dihydrochloride for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0503-2018Class IITerminatedFeb 28, 2018Levetiracetam USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0502-2018Class IITerminatedFeb 28, 2018Leucovorin Calcium USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0501-2018Class IITerminatedFeb 28, 2018Ketoprofen USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0500-2018Class IITerminatedFeb 28, 2018Ketoconazole USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0499-2018Class IITerminatedFeb 28, 2018Ketamine HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0498-2018Class IITerminatedFeb 28, 2018Itraconazole USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0497-2018Class IITerminatedFeb 28, 2018Imiquimod USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0496-2018Class IITerminatedFeb 28, 2018Hydroxyprogesterone Caproate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0495-2018Class IITerminatedFeb 28, 2018Gabapentin USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0494-2018Class IITerminatedFeb 28, 2018Flurbiprofen USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0493-2018Class IITerminatedFeb 28, 2018Fluconazole USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0492-2018Class IITerminatedFeb 28, 2018Estrone USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0491-2018

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.